Sight Sciences names Kashif Rashid Chief Legal Officer; Jeremy Hayden departs

Sight Sciences, Inc.

Kashif Rashid appointed Chief Legal Officer and Corporate Secretary effective Aug 10, 2026; ex-Nevro GC.
Rashid receives $450,000 base salary, 50% target bonus, and $1.4M RSU award vesting over 4 years.
Jeremy Hayden steps down as CLO/Corporate Secretary Aug 10, 2026; stays through Aug 31 for transition.
Hayden to receive one year base salary and up to one year COBRA under separation agreement.
Rashid previously served at Nevro, Atara Biotherapeutics, St. Jude Medical, and GE Healthcare.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kashif Rashid

Chief Legal Officer and Corporate Secretary

SGHT · Sight Sciences, Inc.

Effective: 2026-08-10
Filed: August 10, 2026, 8:21 AM ET

On August 6, 2026, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”) appointed Kashif Rashid to serve as the Company’s Chief Legal Officer and Corporate Secretary, effective August 10, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kashif Rashid was appointed as Chief Legal Officer and Corporate Secretary at Sight Sciences, Inc..

Action: appointed
Role: Chief Legal Officer and Corporate Secretary

Exact text from the filing

On August 6, 2026, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”) appointed Kashif Rashid to serve as the Company’s Chief Legal Officer and Corporate Secretary, effective August 10, 2026.

View on SEC.gov

Sight Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-341346

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.